318 related articles for article (PubMed ID: 35092511)
1. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy.
Li X; Wan Z; Liu X; Ou K; Yang L
Med Oncol; 2022 Jan; 39(4):43. PubMed ID: 35092511
[TBL] [Abstract][Full Text] [Related]
2. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
[TBL] [Abstract][Full Text] [Related]
3. Tertiary lymphoid structures marker CXCL13 is associated with better survival for patients with advanced-stage bladder cancer treated with immunotherapy.
Groeneveld CS; Fontugne J; Cabel L; Bernard-Pierrot I; Radvanyi F; Allory Y; de Reyniès A
Eur J Cancer; 2021 May; 148():181-189. PubMed ID: 33743486
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
Liu Z; Meng X; Tang X; Zou W; He Y
Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
[TBL] [Abstract][Full Text] [Related]
5. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
6. Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer Patients.
Zhang K; Xie X; Zou LH; Guo SQ
Reprod Sci; 2023 Aug; 30(8):2468-2480. PubMed ID: 36759495
[TBL] [Abstract][Full Text] [Related]
7. Genomic properties and clinical outcomes associated with tertiary lymphoid structures in patients with breast cancer.
Wang L; Gong S; Pang L; Zhang S; Zhang X; He W
Sci Rep; 2023 Aug; 13(1):13542. PubMed ID: 37598257
[TBL] [Abstract][Full Text] [Related]
8. The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.
Wang B; Liu J; Han Y; Deng Y; Li J; Jiang Y
Front Immunol; 2022; 13():868155. PubMed ID: 35664009
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation.
Salem D; Chelvanambi M; Storkus WJ; Fecek RJ
Front Immunol; 2021; 12():629519. PubMed ID: 33746966
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Significance of Gene Signature of Tertiary Lymphoid Structures in Patients With Lung Adenocarcinoma.
Feng H; Yang F; Qiao L; Zhou K; Wang J; Zhang J; Tian T; Du Y; Shangguan H
Front Oncol; 2021; 11():693234. PubMed ID: 34381716
[TBL] [Abstract][Full Text] [Related]
11. Pan-cancer analysis of genomic properties and clinical outcome associated with tumor tertiary lymphoid structure.
Lin Z; Huang L; Li S; Gu J; Cui X; Zhou Y
Sci Rep; 2020 Dec; 10(1):21530. PubMed ID: 33299035
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structure signatures are associated with survival and immunotherapy response in muscle-invasive bladder cancer.
Zhou L; Xu B; Liu Y; Wang Z
Oncoimmunology; 2021 May; 10(1):1915574. PubMed ID: 34104539
[TBL] [Abstract][Full Text] [Related]
13. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
Pagliarulo F; Cheng PF; Brugger L; van Dijk N; van den Heijden M; Levesque MP; Silina K; van den Broek M
Front Immunol; 2021; 12():793992. PubMed ID: 35145509
[TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma.
Lynch KT; Young SJ; Meneveau MO; Wages NA; Engelhard VH; Slingluff CL; Mauldin IS
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34103353
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
[TBL] [Abstract][Full Text] [Related]
17. 12-Chemokine signature, a predictor of tumor recurrence in colorectal cancer.
Tokunaga R; Nakagawa S; Sakamoto Y; Nakamura K; Naseem M; Izumi D; Kosumi K; Taki K; Higashi T; Miyata T; Miyamoto Y; Yoshida N; Baba H; Lenz HJ
Int J Cancer; 2020 Jul; 147(2):532-541. PubMed ID: 32191346
[TBL] [Abstract][Full Text] [Related]
18. The 12-CK Score: Global Measurement of Tertiary Lymphoid Structures.
Li R; Berglund A; Zemp L; Dhillon J; Putney R; Kim Y; Jain RK; Grass GD; Conejo-Garcia J; Mulé JJ
Front Immunol; 2021; 12():694079. PubMed ID: 34267760
[TBL] [Abstract][Full Text] [Related]
19. Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma.
Xing A; Lv D; Wu C; Zhou K; Zhao T; Zhao L; Wang H; Feng H
Curr Genomics; 2024 Apr; 25(2):88-104. PubMed ID: 38751598
[TBL] [Abstract][Full Text] [Related]
20. Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer.
Xu Z; Wang Q; Zhang Y; Li X; Wang M; Zhang Y; Pei Y; Li K; Yang M; Luo L; Wu C; Wang W
Front Oncol; 2024; 14():1383096. PubMed ID: 38846981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]